Long-Term Suppression of Tumor Growth by TNF Requires a Stat1- and IFN Regulatory Factor 1-Dependent IFN-γ Pathway but Not IL-12 or IL-18

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 3243-3251

  Wu, Terry H ^a,d   Pabin, Christine N ^a   Qin, Zhihai ^b   Blankenstein, Thomas ^b,c   Philip, Mary ^a   Dignam, James ^a   Schreiber, Karin ^a   Schreiber, Hans ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 18; STAT1 PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE; HOST CELL; IN VITRO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH;

EID: 1342282158     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.3243     Document Type: Article

References (41)

1. Poehlein, C. H., H. Hu, J. Yamada, I. Assmann, W. G. Alvord, W. J. Urba, and B. A. Fox. 2003. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-γ double knockout effector T cells. J. Immunol. 170:2004.
2. Asher, A. L., J. J. Mule, A. Kasid, N. P. Restifo, J. C. Salo, C. M. Reichert, G. Jaffe, B. Fendly, M. Kriegler, and S. A. Rosenberg. 1991. Murine tumor cells transduced with the gene for tumor necrosis factor-α: evidence for paracrine immune effects of tumor necrosis factor against tumors. J. Immunol. 146:3227.
3. Vanhaesebroeck, B., M. Mareel, F. Van Roy, J. Grooten, and W. Fiers. 1991. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo. Cancer Res. 51:2229.
4. Blankenstein, T., Z. Qin, K. Uberla, W. Muller, H. Rosen, H. Volk, and T. Diamantstein. 1991. Tumor suppression after tumor cell-targeted tumor necrosis factor-α gene transfer. J. Exp. Med. 173:1047.
5. Teng, M. N., B. H. Park, H. K. W. Koeppen, K. J. Tracey, B. M. Fendly, and H. Schreiber. 1991. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T cell immunity. Proc. Natl. Acad. Sci. USA 88:3535.
6. Musiani, P., A. Allione, A. Modica, P. L. Lollini, M. Giovarelli, F. Cavallo, F. Belardelli, G. Forni, and A. Modesti. 1996. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ and TNF-α. Lab. Invest. 74:146.
7. Matory, Y. L., D. M. Dorfman, L. Wu, M. Chen, P. Goedegebuure, and T. J. Eberlein. 1999. Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-α gene transfected mammary tumor. Pathobiology 67:186.
8. Lewis, M., L. A. Tartaglia, A. Lee, G. L. Bennett, G. C. Rice, G. H. W. Wong, E. Y. Chen, and D. V. Goeddel. 1991. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88:2830.
9. Himeno, T., N. Watanabe, N. Yamauchi, M. Maeda, Y. Tsuji, T. Okamoto, H. Neda, and Y. Niitsu. 1990. Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res. 50:4941.
10. Vanhaesebroeck, B., E. Decoster, X. Van Ostade, S. Van Bladel, A. Lenaerts, F. Van Roy, and W. Fiers. 1992. Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis. J. Immunol. 148:2785.
11. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Blüthmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
12. Stauss, H. J., C. Van Waes, M. A. Fink, B. Starr, and H. Schreiber. 1986. Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer. J. Exp. Med. 164:1516.
13. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells. Immunity 12:677.
14. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
15. Hock, H., M. Dorsch, U. Kunzendorf, Z. Qin, T. Diamantstein, and T. Blankenstein. 1993. Mechanism of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon γ. Proc. Natl. Acad. Sci. USA 90:2774.
16. + T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ. Proc. Natl. Acad. Sci. USA 96:8633.
17. Oliff, A., D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, and S. H. Socher. 1987. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50:555.
18. Blanchard, D. K., J. Y. Djeu, T. W. Klein, H. Friedman, and W. E. Stewart II. 1986. Interferon-γ induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J. Immunol. 136:963.
19. Ramana, C. V., M. P. Gil, Y. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. USA 98:6674.
20. Seung, L. P., R. R. Weichselbaum, A. Toledano, K. Schreiber, and H. Schreiber. 1996. Radiation can inhibit tumor growth indirectly while depleting circulating leukocytes. Radiat. Res. 146:612.
21. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses Immunity 4:471.
22. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.
23. Lukacs, N. W., S. L. Kunkel, R. Allen, H. L. Evanoff, C. L. Shaklee, J. S. Sherman, M. D. Burdick, and R. M. Strieter. 1995. Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. Am. J. Physiol. 268:L856.
24. Ngo, V. N., H. Komer, M. D. Gunn, K. N. Schmidt, D. S. Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster. 1999. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403.
25. Pinhal-Enfield, G., M. Ramanathan, G. Hasko, S. N. Vogel, A. L. Salzman, G. J. Boons, and S. J. Leibovich. 2003. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am. J. Pathol. 163:711.
26. Ming, W. J., L. Bersani, and A. J. Mantovani. 1987. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138:1469.
27. Mano-Hirano, Y., N. Sato, Y. Sawasaki, K. Haranaka, N. Satomi, H. Nariuchi, and T. Goto. 1987. Inhibition of tumor-induced migration of bovine capillary endothelial cells by mouse and rabbit tumor necrosis factor. J. Natl. Cancer Inst. 78:115.
28. Moldovan N. I. 2002. Role of monocytes and macrophages in adult angiogenesis: a light at the tunnel's end. J. Hematother. Stem Cell Res. 11:179.
29. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: intefferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189:1315.
30. Fehniger, T. A., H. Yu, M. A. Cooper, K. Suzuki, M. H. Shah, and M. A. Caligiuri. 2000. IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-γ production in vivo. J. Immunol. 164:1643.
31. Coughlin, C. M., K. E. Salhany, M. S. Gee, D. C. LaTemple, S. Kotenko, X. J. Ma, G. Gri, M. Wysocka, J. E. Kim, L. Liu, et al. 1998. Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and anti-angiogenesis. Immunity 9:25.
32. Keller, R., R. Keist, T. P. Leist, and P. H. van der Meide. 1990. Resistance to a non-immunogenic tumor, induced by Corynebacterium parvum of Listeria monocytogenes, is abrogated by anti-interferon γ. Int. J. Cancer 46:687.
33. Doherty, G. M., H. R. Alexander, M. J. Merino, D. J. Venzon, and J. A. Norton. 1996. Role of endogenous interferon γ in murine tumor growth and tumor necrosis factor a antitumor efficacy. Ann. Surg. Oncol. 3:198.
34. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumor. Proc. Natl. Acad. Sci. USA 72:3666.
35. Haranaka, K., N. Satomi, and A. Sakurai. 1984. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int. J. Cancer 34:263.
36. Havell, E. A., W. Fiers, and R. J. North. 1988. The antitumor function of tumor necrosis factor (TNF) I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J. Exp. Med. 167:1067.
37. Fraker, D. L., B. C. Sheppard, and J. A. Norton. 1990. Impact of tolerance on antitumor efficacy of tumor necrosis factor in mice. Cancer Res. 50:2261.
38. Delneste, Y., P. Charbonnier, N. Herbault, G. Magistrelli, G. Caron, J. Y. Bonnefoy, and P. Jeannin. 2003. Interferon-γ switches monocyte differentiation from dendritic cells to macrophages. Blood 101:143.
39. Klimp, A. H., E. G. de Vries, G. L. Scherphof, and T. Daemen. 2002. A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44:143.
40. Mills, C. D., K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill. 2000. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164:6166.
41. Tamura, T., T. Nagamura-Inoue, Z. Shmeltzer, T. Kuwata, and K. Ozato. 2000. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13:155.